Meta-terminology of Ameloblastoma

Abstract

One of the primary tasks of systematic biology is the development of our biological nomenclature and classifications. The key purpose for the development of a standard nomenclature for a disease is the need for a common language for the statement of diagnostic terms and for a means or system whereby diagnosis could be suitably recorded without chaos. Odontogenic tumor nomenclature and classification have confused physicians over the years. Ameloblastoma is one such entity among odontogenic tumors, which has continuously changed to be an evolution of the terms and taxonomy used in literature. In this review, we aim to provide a fundamental basis for the understanding of how the etymology and the position of ameloblastoma in odontogenic tumor classification have evolved over the years.

A Case Report on Acanthomatous Ameloblastoma of the Anterior Mandible with Brief Review on Advanced Imaging Diagnosis

“…He termed this lesion as odontomes embryoplastiques, which mean embryoplastic odontomas. 3 It was designated as “adamantinoma” in 1885 by the French physician Louis-Charles Malassez. 4 Churchill and Ivy described that the name adamantinoma indicates the neoplasm as calcified and hence coined the term ameloblastoma in 1930.…”

“… 4 Churchill and Ivy described that the name adamantinoma indicates the neoplasm as calcified and hence coined the term ameloblastoma in 1930. 3 4 There is no predilection for sex. The peak incidence is in the third and fourth decades of life with the median age at presentation being 35.9 years and an age range of 4 to 92 years.…”

Immunohistochemical analysis of Nuclear Factor-kappa B (NF-κ B) between follicular and plexiform ameloblastomas: A pilot study

“…[ 1 2 ] This tumor was found even from the prehistoric era through the archaeologically obtained human skeletons. [ 3 ] In recent years, ameloblastoma has undergone constant modifications in terminology and classification with the introduction of prospective views based on updates on current genetic studies. [ 4 ] The proliferating activities of ameloblastoma cells vary depending on the histological type and cytological pattern.…”

Immunohistochemical detection of nerve growth factor (NGF) in follicular and plexiform ameloblastoma – A novel study

“…Ameloblastoma was described by Robinson as a benign tumor that is usually “unicentric, non-functional, intermittent in growth, anatomically benign and clinically persistent.”[ 2 ] The following are the several histopathological subtypes—follicular, plexiform, acanthomatous, desmoplastic, granular cell, and basal cell pattern that may occur singly or in combination of two or more types. The most commonly encountered are the follicular and plexiform variants accounting for 32.5% and 28.2.%, respectively, which is followed by the acanthomatous subtype 12.1%, whereas the extremely uncommon desmoplastic variant has incidence rates ranging from 4% to 13%.…”